Lomustine (INN; abbreviated as CCNU; original brand name CeeNU, now marketed as Gleostine) is an alkylating nitrosourea compound used in chemotherapy. It is closely related to semustine …

Feb 6, 2023 · CeeNU (lomustine) is a cancer (antineoplastic) medication used to treat brain tumors and Hodgkin's disease, and is sometimes given with other cancer medications. What …

CeeNU is available in 10 mg, 40 mg, and 100 mg capsules for oral administration. CLINICAL PHARMACOLOGY . Although it is generally agreed that CeeNU alkylates DNA and RNA, it is …

From CeeNU ® To Gleostine ® Prior to 2013, CeeNU ® (lomustine) was manufactured by Bristol-Myers-Squibb but in limited quantities, resulting in short supply of this key component used in …

Jan 8, 2025 · Detailed drug Information for Ceenu. Includes common brand names, drug descriptions, warnings, side effects and dosing information.

CCNU/Gleostine (CeeNu, lomustine) Lomustine is a chemotherapy drug commonly used in patients experiencing recurrent brain tumors. It is one of the oldest chemotherapy drugs on the …

Jul 4, 1974 · CeeNU (lomustine-CCNU) is indicated as palliative therapy in addition to surgery and radiotherapy or in combination therapy with other chemotherapeutic agents in the following: 1.

LOMUSTINE (loe MUS teen) treats brain cancer and lymphoma. It works by slowing down the growth of cancer cells. This medicine may be used for other purposes; ask your health care …

Lomustine is FDA approved as a secondary therapy in combination with other drugs to treat people with Hodgkin lymphoma who relapse while being treated with primary therapy or who …

Lomustine (CeeNU) is an antitumour agent, cancer chemotherapeutic agent, cytotoxic agent and alkylating agent. Chemically, lomustine is similar to the other nitrosoureas carmustine